Newsmaker Interviews 11/17/2005
Fourth MIM Pan-African Malaria Conference and RBM Forum V, Yaoundé, Cameroon
This page features interviews with newsmakers summarizing developments from the Fourth MIM Pan-African Malaria Conference and RBM Forum V.
Awa-Marie Coll-Seck, M.D., Ph.D.
( video
)
(
podcast
)
(
transcript )
Awa-Marie Coll-Seck, M.D., Ph.D., executive secretary of Roll Back Malaria, talks with kaisernetwork.org about how Forum V will be different from other RBM meetings; the importance of sharing success stories that give malaria endemic countries hope; and what she sees as the top challenges for preventing malaria.
Melinda Moree, Ph.D.
( video
)
(
podcast
)
(
transcript )
Melinda Moree, Ph.D., director of PATH Malaria Vaccine Initiative, talks with kaisernetwork.org about progress being made in developing an effective vaccine, including GlaxoSmithKline's RTS,S, also known as Mosquirix, which was found to protect children from malaria for up to 18 months. Dr. Moree also discusses vaccine research funding and the need for a multi-faceted approach to fighting malaria.
Wilfred Mbacham, Ph.D.
( video
)
(
podcast
)
(
transcript )
Professor Mbacham, associate professor, Public Health and Biotechnology, The Biotechnology Centre, University of Yaounde and Local MIM Organizing Secretariat, talks with kaisernetwork.org about building and maintaining capacity for African scientists; how the MIM conference will help translate scientific advances into real world results; and the future of MIM as the secretariat moves back to Africa.Wilfred Mbacham also is founder and president of the Fobang Foundation.
Sign up for
email alerts and stay informed about upcoming HealthCasts, and the latest health policy issues, news, and events.
Change Your Video Preferences
